Melanie Kelly is a Professor In Pharmacology and Ophthalmology at Dalhousie University. She works in a collaborative multidisciplinary vision research laboratory, the laboratory for Retina and Optic Nerve Research, within the Faculty of Medicine, Dalhousie University.
Melanie Kelly’s primary research expertise is pharmacology, specifically, receptors and cell signaling pathways. Professor Kelly’s laboratory has experience working with both in vitro and in vivo models of retinal disease. Her work has examined pathways important in survival of retinal ganglion cells in experimental models of glaucoma and has made use of gene mutations, to explore signaling pathways involved in retinal progenitor cell growth and development.
Current research addresses the pharmacology of the endocannabinoids and lipid signaling in the mammalian eye, with a specific focus on the regulation of intraocular pressure and interactions between glial cells and microvasculature in the regulation of retinal blood flow.
Read about some of the researchers who currently received grants from the Glaucoma Research Society